May 2020 FDA Recall Drug by Exela Pharma Sciences Llc
D-1585-2020 - Short Fill

This Class III drug recall was voluntarily initiated by Exela Pharma Sciences Llc on May 5, 2020 for the product Drug. The FDA reported the reason for recall as short fill. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1585-2020

Reason for Recall
Short Fill
Initiated
05-05-2020
Reported
09-23-2020
Quantity
23,775 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
86288
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Exela Pharma Sciences LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
01-14-2022
Product Description About Product Description
Full technical description of the product.
Potassium Acetate Injection, USP 40 mEq/20 mL (2 mEq/mL) Single Dose Vials, Rx only, Manufactured By: Exela Pharma Sciences, LLC. Lenoir, NC NDC 51754-2001-4

Batch or Lot Expiration Information

Lot# P0000471, Catalog #2020TS002, Exp Date: 04/2021